Advertisement.

APM Projected Dividend Yield

Cl A Ord (New) $0.00001 USD/Aptorum Group Ltd (New) ( NASDAQ : APM )

Aptorum Group is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs. In addition, Co. is also pursuing in the therapeutic projects in neurology, gastroenterology, metabolic disorders, women's health and other disease areas. Co.'s Lead Projects are: ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus including but not limited to Methicillin-resistant Staphylococcus aureus; SACT-1, repurposed frug for the treatment of Neuroblastoma; and RPIDD, a molecular-based rapid pathogen identification and detection diagnostics technology.

20 YEAR PERFORMANCE RESULTS

APM Dividend History Detail
APM Dividend News
APM Competitors News

# of Shares: 0

Closing Price: 0.77

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000